2014
DOI: 10.1001/jama.2014.6421
|View full text |Cite
|
Sign up to set email alerts
|

Breast Cancer Screening

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

2016
2016
2019
2019

Publication Types

Select...
3
3

Relationship

0
6

Authors

Journals

citations
Cited by 20 publications
(4 citation statements)
references
References 17 publications
0
4
0
Order By: Relevance
“…Sample images of breast and lesions are presented in Figure 2. The lesion characteristics were adjusted during several prepilot stages to achieve a DM performance comparable to reported values …”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…Sample images of breast and lesions are presented in Figure 2. The lesion characteristics were adjusted during several prepilot stages to achieve a DM performance comparable to reported values …”
Section: Methodsmentioning
confidence: 99%
“…The evaluation of novel imaging technologies for screening typically requires a substantial clinical trial to demonstrate benefits compared with the standard of care. 1 For example, regulatory approvals of digital breast tomosynthesis (DBT) are supported by clinical trials involving significant resources. A recent submission to the US Food and Drug Administration (FDA) of a DBT system as a replacement for digital mammography (DM), for example, 2 relied on a clinical trial involving 400 women in 7 clinical sites receiving double exposure to ionizing radiation over many years, with 31 participating radiologists.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Concerns about harm from false positive and false negative diagnoses [2] create a considerable incentive for development of improved mammographic techniques. Improving sensitivity and specificity of existing breast cancer imaging technologies, could improve detection [3]; doing this while delivering reduced Xray dose to the patient, and, preferably, also removing or reducing the considerable physical discomfort experienced by many patients during the conventional breast screening procedures [4][5][6][7][8][9] would be an added benefit. Propagation-based phase-contrast X-ray CT (PB-CT), which exploits refraction (in addition to absorption) of X-rays in tissue, shows particular promise in this regard due to its superior sensitivity to soft-tissue tumors [5][6][7][8][9][10][11][12][13][14][15][16][17].…”
mentioning
confidence: 99%